Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-02-11 @ 9:09 PM
Study NCT ID:
NCT02704858
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2016-01-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
Sponsor:
Neonc Technologies, Inc.
Organization: